A very common strategy in the tauopathies market is that companies are entering into licensing partnerships for the co-development of products.
Contributed Author: 
Akiko Fukui, MSc, Healthcare Analyst, GlobalData

Original Article: Tauopathies Market Entry Requires Shrewd Strategies from Pharma Companies


More From BioPortfolio on "Tauopathies Market Entry Requires Shrewd Strategies from Pharma Companies"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

News Quicklinks